Clik here to view.
Verastem Reports Data from Phase 1 Study of VS-6063 (defactinib) in Japanese...
CAMBRIDGE, Mass. Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today presented preliminary data from an...
View ArticleClik here to view.
日本人患者を対象にした VS-6063 ( defactinib ) の第1相試験のデータをVerastem社が発表
米国マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — がん幹細胞の選択的殺傷によるがん治療の薬剤開発を中心に行っているVerastem 社 ( NASDAQ: VSTM ) は本日、日本人患者を対象に行われている VS-6063 ( defactinib )...
View ArticleClik here to view.
パスウェイ・ゲノミクスが初の次世代シーケンシングシステムIllumina NextSeq 500を追加
サンディエゴ （ビジネスワイヤ） — 米サンディエゴに拠点を置き、CLIAおよびCAPの認定を受けて遺伝子検査サービスを世界規模で提供している臨床ラボラトリーのパスウェイ・ゲノミクス・コーポレーションは本日、Illumina NextSeq 500システムを当社の一連のNGS（次世代シーケンシング）シーケンサーに追加し、当社の定評ある高効率検査プロセスを強化したと発表しました。 NextSeq...
View ArticleClik here to view.
Merck’s Consumer Health Division Breaks $1bn Barrier Through Transition of...
Smart Multimedia Gallery Floratil and Neurobion; brands that have been incorporated into Merck Consumer Health (Photo: Business Wire) View and Share Photo Download Small DARMSTADT, Germany Merck’s...
View ArticleClik here to view.
Pathway Genomics购入下一代测序系统：首个 Illumina NextSeq 500
圣迭戈 (美国商业资讯)–Pathway Genomics 公司位于圣迭戈，是一家获CLIA和CAP认证的临床实验室，可为全球提供基因检测服务，该公司今天宣布Illumina NextSeq 500系统已加入其NGS 测序仪家族，这将强化公司成熟高效的实验流程。 NextSeq...
View ArticleClik here to view.
22nd Century集团普通股获准在NYSE MKT上市
纽约州克拉伦斯 (美国商业资讯)–22nd Century Group, Inc. (OTCQB:XXII)今日宣布，公司普通股已获批在纽交所市场(NYSE MKT)上市。该公司普通股预计于2014年3月11日周二在纽交所市场开始交易，股票代码为公司目前的代码XXII。在纽交所市场上市之后，22nd Century集团将停止在场外柜台交易系统(OTCBB)和OTCQB交易。 22nd...
View ArticleClik here to view.
独立研究により、V.A.C. VeraFlo™ Therapyが従来のV.A.C.® Therapyより有効であることが判明
サンアントニオ （ビジネスワイヤ） — キネティック・コンセプツは本日、Plastic and Reconstructive Surgery誌に掲載された独立の後ろ向き研究で、陰圧創傷治療システムV.A.C.Ulta™を使用したV.A.C. VeraFlo™ Therapyによる補助療法が、従来のV.A.C.®...
View ArticleClik here to view.
独立研究显示：与传统V.A.C.®疗法相比，V.A.C. VeraFlo™ 疗法更为有益
圣安东尼奥哥 (美国商业资讯) –Kinetic Concepts 公司今天宣布，Plastic and Reconstructive Surgery（《整形与整复外科》杂志）上发表的一项独立回顾性研究表明：采用 V.A.C.Ulta™ 负压伤口疗法系统的V.A.C. VeraFlo™ 疗法辅助治疗的手术室（OR）就诊次数、至最终手术时间和留诊时间显著低于传统V.A.C.®疗法。*...
View ArticleClik here to view.
Fibrotech announces positive Phase Ia results for anti-fibrotic FT011
MELBOURNE, Australia Fibrotech, an Australian biopharmaceutical company developing a new class of drugs to prevent a massive health burden associated with fibrosis, today announced that its lead...
View ArticleClik here to view.
Mainstay Medical Begins Clinical Trial of ReActiv8® for People with Chronic...
Smart Multimedia Gallery Peter Crosby, CEO, Mainstay Medical (Photo: Business Wire) View and Share Photo Download Small DUBLIN Mainstay Medical today announced that it has secured approval from...
View ArticleClik here to view.
WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System
SAN DIEGO & SHANGHAI Illumina, Inc. (NASDAQ:ILMN) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company with...
View ArticleClik here to view.
Integrity Applications Signs Three Additional Distribution Agreements for Its...
ASHKELON, Israel Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary,...
View ArticleClik here to view.
Catalent Announces Agreement for One of the First Regenerative Therapies to...
SOMERSET, N.J. Catalent Pharma Solutions, the global leader in advanced delivery technologies and development solutions for drug, biologic and consumer health products, today announced an agreement...
View ArticleClik here to view.
Clik here to view.
CORRECTING and REPLACING Integrity Applications Signs Three Additional...
ASHKELON, Israel First graph of release should read: Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered,...
View ArticleClik here to view.
ResearchDx, the Leading Contract Diagnostics Organization, Sponsors the Asia...
SINGAPORE ResearchDx, LLC of Irvine, California, USA today announced its sponsorship and attendance at the Asia BioPharm 2014 Convention in Singapore as part of its focus on the important Asian...
View ArticleClik here to view.
R-Tech Ueno: Announcement of Collaborative Research with Keio University for...
TOKYO R-Tech Ueno, Ltd. (JASDAQ:4573): We announce the launch of a collaborative research on graft-versus-host disease (GVHD) with Professor Kazuo Tsubota’s group, Department of Ophthalmology, Keio...
View ArticleClik here to view.
Almac Expands Asia Pacific Operations, Establishes Regional Operations Centre...
CRAIGAVON, Northern Ireland Almac today announced the expansion of its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and...
View ArticleClik here to view.
Clinipace Worldwide Expands into Asia with Acquisition of Choice Pharma
MORRISVILLE, N.C. Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice Pharma, a Pan-Asian contract research...
View ArticleClik here to view.
M&A Slowdown and Drop in FDA Approvals Stifles Growth of Medtech Sector in 2013
LONDON & BOSTON & TOKYO At the half-year mark, the medtech sector was on course for its worst year in a decade in terms of M&A activity, EP Vantage concluded last fall in its Half Year...
View Article